Αποτελέσματα Αναζήτησης
18 Νοε 2011 · All employees of SurModics Pharmaceuticals, Inc., will transfer to Evonik, assuring full business continuity from the first day. The Birmingham, Alabama-based business will be integrated in Evonik Degussa Corporation, headquartered in Parsippany, N.J.
Surmodics is a leading provider of chemical components for in vitro diagnostic tests and microarrays. We enable sensitive, reproducible, and robust diagnostic technologies.
Surmodics’ leadership in surface technologies dates to our development of the drug-delivery coating for the first drug-eluting stent. Since then, we’ve consistently pioneered breakthrough lubricious, hemocompatible, and drug-delivery COATINGS for the world’s leading medical device companies.
Find company research, competitor information, contact details & financial data for SurModics Pharmaceuticals, Inc. of Birmingham, AL. Get the latest business insights from Dun & Bradstreet.
30 Μαΐ 2012 · Evonik acquired the assets of SurModics Pharmaceuticals Inc., a subsidiary of SurModics Inc., and named the facility Birmingham Laboratories. The facility specializes in drug delivery technologies and manufacturing for pharmaceutical, biotechnology, and medical device companies.
1 Νοε 2011 · SurModics, Inc. has announced the signing of a definitive agreement with Evonik Industries AG under which it will sell its SurModics Pharmaceuticals assets to Evonik for a total of $30 million in cash.
2 Νοε 2011 · SurModics is selling its SurModics Pharmaceuticals assets to Germany’s specialty chemicals firm Evonik Industries for $30 million in cash.
